EC Number   |
Natural Substrates |
|---|
   1.17.3.2 | 1-methylxanthine + H2O + O2 |
- |
| 1.17.3.2 | 6-mercaptopurine + 2 H2O + 2 O2 |
- |
| 1.17.3.2 | 6-mercaptopurine + 2 H2O + 2 O2 |
an anticancer prodrug, no activation by xanthine oxidase but conversion to the inactive metabolite 6-thiouric acid, catabolism, overview |
| 1.17.3.2 | 6-mercaptopurine + H2O + O2 |
an anticancer drug |
| 1.17.3.2 | carboxylic aldehyde + H2O + O2 |
enzyme is implicated in the control of various redox reactions in the cell, in milk: assures absorption of iron from the gut, coupling antibacterial effect via the lactoperoxidase system |
| 1.17.3.2 | hypoxanthine + 2 H2O + 2 O2 |
- |
| 1.17.3.2 | hypoxanthine + 2 H2O + 2 O2 |
production of superoxide radicals |
| 1.17.3.2 | hypoxanthine + NAD+ + H2O |
- |
| 1.17.3.2 | more |
xanthine oxidase is necessary during the physiological involution of tissues |
| 1.17.3.2 | more |
chronic enzyme inhibition by allopurinol or febuxostat cannot prevent or treat the progression of congestive heart failure induced by coronary artery ligation in rabbits, overview |
